Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS) — Stock Score Summary

Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS) has a MoatMap StockRank of 44/100 based on Quality (59/100), Value (27/100), and Momentum (45/100) factor scores. The current signal is HOLD. Liaoning Chengda Biotechnology is a vaccine manufacturer facing domestic pricing pressure and lacks the global scale or CDMO pricing power required for our portfolio.

Liaoning Chengda Biotechnology Co., Ltd. is a leading biopharmaceutical company specializing in the development and manufacture of vaccines for human use, most notably its flagship rabies vaccine. The company is the largest producer of human rabies vaccines in China, utilizing advanced bioreactor cell culture technology to ensure high quality and yield. Its established brand reputation and extensive domestic and international distribution networks form a highly defensive competitive moat.

Key Financial Metrics

Price$2.98
Market Cap$1.3B
P/E (TTM)149.43
P/E (Forward)38.74
Price/Book0.92
Return on Equity0.6%
Return on Invested Capital1.8%
Debt/Equity0.10
Gross Margin70.1%
Operating Margin-0.7%
Revenue Growth-23.7%
Dividend Yield0.5%
Free Cash Flow$-4M

Liaoning Chengda Biotechnology Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Liaoning Chengda Biotechnology Co.,Ltd.’s (688739.SS) StockRank?
MoatMap’s StockRank for Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS) is 44/100, with a Hold signal. It is a composite of Quality (59), Value (27), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does Liaoning Chengda Biotechnology Co.,Ltd. have an economic moat?
Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Liaoning Chengda Biotechnology Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS) is Hold, based on a StockRank of 44/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Liaoning Chengda Biotechnology Co.,Ltd. in?
Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).